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Abstract The concentrations of various trace elements in am-
niotic fluid (AF) change over the course of pregnancy, with
gestational age and fetus growth. The aim of the present study
was to evaluate the concentrations of selected essential and
toxic elements in AF and their relations to maternal and fetal
parameters. The study was carried out in 39 pregnant women,
aged 34.6±4.7 years, between weeks 16 and 26 of gestation.
Amniotic fluid samples were obtained during the standard
procedure of amniocentesis in high-risk patients for chromo-
somal abnormalities. An inductively coupled plasma mass
spectrometry (ICP-MS) technique was used to determine the
levels of Al, As, Ba, Cd, Co, Cr, Cu, Mg, Mn, Ni, Sr, U, and V
in AF. Body mass and blood pressure were measured in all the
women. The basic parameters of fetal development were also
assayed. It was found that the age of the mother, the gender of
the fetus, and the week of the pregnancy may affect the con-
centrations of mineral in the amniotic fluid. Moreover, several
significant correlations between the essential and toxic
elements and maternal and fetal parameters were observed.
In particular, negative and positive correlations between fetal
parameters and magnesium and copper levels in AF, respec-
tively, were seen. The present findings demonstrate the asso-
ciation between minerals in AF and fetal development.
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Introduction
During pregnancy, amniotic fluid (AF) surrounds the fetus and
is circulated constantly by the baby’s inhalation and exhala-
tion, as well as swallowing and urination, of the fluid.
Maternal plasma—the source of the water in AF—passes
through the fetal membranes under hydrostatic and osmotic
forces. Through the vessels that develop in the placenta and
fetus, water and solute from the maternal plasma pass across
the placenta to the fetus and then to the AF. It can thus be
assumed that the composition of AF reflects the composition
of the fetal plasma [1]. The composition of AF depends on the
mother’s nutrition, including essential nutrients, and also on
the mother’s exposure to toxic substances. It has been found
that proteins or peptides in the amniotic fluid possess potent
bioactivity on cellular growth and proliferation and that they
modulate the process of embryonic development [2].
The role of trace elements contained in AF is not clear.
Because AF is swallowed by the fetus, it has been suggested
that this fluid may be an important source of certain trace
elements for fetal nutrition. AF is thus considered a valuable
marker of prenatal mineral status and exposure to toxic metals.
Only a few investigations to date have evaluated the con-
centration of minerals in AF. Some studies have determined
the essential elements levels in AF, and attempts have been
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made to establish normal values for the early weeks of preg-
nancy [1, 3]. In other studies, it was demonstrated that heavy
metals may accumulate in AF from a very early stage of ges-
tation; however, little is known about the influence of metals
in AF on fetal development or about the long-term effects of
this early exposure [4].
However, there is a lack of standards and reference ranges
for the concentrations of elements in AF by gestational age. It
is not clear what factors determine the concentration of min-
erals in the AF. Little is known about the relationship between
the concentration of elements in AF and fetal development.
Accordingly, the aim of this study was to evaluate the concen-
tration of selected essential and toxic elements in AF and their
relations with maternal and fetal parameters.
Material and Methods
The study protocol was approved by the Bioethics
Commission at Poznan University of Medical Sciences (ap-
proval no. 30/15). Informed consent was obtained from all
women. The study was performed in accordance with
Helsinki Declaration.
Subjects
The study was carried out on 39 pregnant women, aged 34.6±
4.7 years. The mean gestational age was 20 weeks (range, 16–
26 weeks). The inclusion criteria were (1) intrauterine preg-
nancy, (2) pregnancy without congenital anomalies evaluated
in ultrasound, (3) lack of signs and symptoms indicating risk
of miscarriage (bleeding, pelvic pain, chorionic hematoma),
and (4) informed consent. The exclusion criteria were (1) ec-
topic or heterotopic pregnancy, (2) multiple pregnancies, (3)
positive obstetric history of multiple miscarriages, preterm
birth, and fetal growth disorders (growth restriction,
macrosomia), (4) observed birth defects or genetic conditions
in the current pregnancy or present in the women, (5) use of
drugs that affect the mineral balance in the organism, (6) dia-
betes, (7) infection, (8) gestational hypertension, and (9) ma-
ternal exposure to alcohol, cocaine, or tobacco smoke.
The full characteristics for the subjects are presented in
Table 1. All subjects were informed of the study’s aims, pro-
cedures, and measurement methods, and the individual con-
sent of each patient was obtained.
Maternal Parameters Measurements
The body mass was calculated using the measurements of
women wearing light clothing with bare feet. Weight was
measured to the nearest 0.10 kg accuracy.
Resting arterial blood pressure was measured using regular
adult cuffs. The measurements were obtained in a sitting po-
sition with the legs uncrossed and the back and arms support-
ed. Blood pressure was measured three times, and an average
value was calculated, according to the guidelines of the
European Society of Hypertension [5].
Measurement of Fetal Parameters
Fetal parameters, such as fetal heart rate (FHR), umbilical
artery pulsatility index (UAPI), biparietal diameter (BPD),
abdominal circumference (AC), head circumference (HC), fe-
mur length (FL), and estimated fetal weight (EFW), were
measured using ProSound Alpha7 (Aloka Co.) with convex
5–7 MHz probe. The fetal measurements followed the stan-
dard protocols for fetal biometry [6].
Amniotic Fluid
Amniotic fluid (AF) samples were obtained (5 mL) as a resi-
due after genetic analysis as a result for amniocentesis.
Samples were collected by transabdominal puncture using
plastic syringes free of trace element contamination.
AF samples were centrifuged (3000 rpm/min for 10 min at
4 °C), frozen, and stored at −80 °C.
Table 1 Maternal and fetal parameters (n=39)
Parameters Mean±SD Median Range (min–max)
Maternal
parameters
Sys (mmHg) 125.1±12.5 126 102–153
Dia (mmHg) 73.4±7.8 74 59–91
Body mass (kg) 68.0±10.3 66 50–90
Age (years) 34.6±4.7 34 24–42
Week of pregnancy 20.3±3.0 20.5 16–26
Fetal parameters
FHR 148.6±8.9 150 135–178
UAPI 1.41±0.48 1.29 0.63–2.77
HC (mm) 140.0±34.7 132.5 90.9–213
AC (mm) 120.4±29.7 115.1 70.5–179
FL (mm) 24.0±8.2 20.9 12.2–41.0
EFW (g) 232.8±134.5 189.8 84.0–561.1
Sys systolic blood pressure, Dia diastolic blood pressure, FHR fetal heart
rate,UAPI umbilical artery pulsatility index, BPD biparietal diameter, AC
abdominal circumference, HC head circumference, FL femur length,
EFW estimated fetal weight, SD standard deviation
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Measurement of Minerals in Amniotic Fluid
Sample Preparation
After collection, amniotic fluid samples were immediately
frozen and stored for analysis. Just prior to analysis, the sam-
ples were thawed and underwent digestion in a microwave
oven model Ethos One (Milestone Srl, Italy). The samples
for digestion were prepared as follows: 1 mL of the sample
was transferred to the digestion vessels and 0.5 mL of 65 %
nitric acid (Merck, Germany) and 0.5 mL of 30 % hydrogen
peroxide (Fluka, Germany) were added to each vessel. The
microwave oven heating program proceeded in steps: (1)
ramp time of 20 min to reach 1500 W, (2) hold time of
30 min at 1500 W, and (3) cooling for 30 min. The tempera-
ture during the digestion process was 180 °C. The digested
samples were quantitatively transferred into volumetric flasks,
which had previously been prepared appropriately, first by
soaking in 5 % nitric acid for 24 h and then rinsed with de-
ionized water. The digests were adjusted to 10 mL with de-
ionized water (TKA Smart2Pure, Niederelbert, Germany). In
parallel, the procedural blanks, including the same reagents as
the samples, were prepared and digested in the same way as
the samples in each digestion run.
Analytical Procedure
An Elan DRC II ICP-MS (PerkinElmerSCIEX, Ontario,
Canada) was used to determine Al, As, Ba, Cd, Co, Cr, Cu,
Mg, Mn, Ni, Sr, U, and V levels. A cyclonic spray chamber, a
concentric glass nebulizer, and a quartz torch with a quartz
injector were used. A quadrupole mass analyzer with gold-
coated parallel rods was employed, as was an electron multi-
plier as the detector. Signal intensity was recorded as a
counting signal or analog signal, each with its own detection
range. The operating conditions for the inductively coupled
plasma mass spectrometer (ICP-MS) were as follows: RF
power was 1100 W; plasma Ar flow rate was 15 L/min; neb-
ulizer Ar flow rate was 0.86 L/min and auxiliary Ar flow rate
was 1.2 L/min; and lens voltage was 7.0–9.5 V. Argon with a
purity of 99.999 % was used as a nebulizer, auxiliary, and
plasma gas (Linde Gaz, Poland). A mixed standard solution
(Multielement Calibration Standard 3, Atomic Spectroscopy
Standard, PerkinElmer Pure) containing analyzed elements at
a concentration of 10 mg L−1 was used to construct calibration
curves. The calibration curves for the elements were con-
structed in the range of 0.01 to 50 μg L−1. The isotopes of
45Sc, 74Ge, 103Rh, and 159Tb prepared from individual solu-
tions with a concentration of 1000 mg L−1 were applied as
internal standards in order to eliminate nonspectral interfer-
ences (ICP Standard CertiPUR, Merck, Germany). In turn,
spectral interference was eliminated through the use of a dy-
namic reaction cell (DRC). As the DRC reaction gas, high-
purity ammonia (99.999 %) was used. Deionized water was
used throughout the experiment [7].
Figures of Merit and Analytical Performance
After calibration, and also during the analysis, measurements
were controlled by analysis of standard solutions at concen-
trations of 1 or 5 μg L−1 and certified reference materials after
each batch of ten samples. Calibration curves for all elements
proved to be linear over the whole concentration range, which
resulted in good correlation coefficients of at least 0.999. In
order to ensure the reliability of the applied analytical proce-
dure, analysis of the certified reference material is highly rec-
ommended. The accuracy of the method for the elements un-
der investigation was evaluated by analyzing ten samples of
the certified reference material of river water SLRS-5 and
fortified lake water TM 27.3. The obtained values are present-
ed in Table 2. Within day precision was calculated as the
relative standard deviation and expressed in a percentage as
the variation coefficient. The precision values for all the tested
elements fell in the range from 1.2 to 22.2 % for SLRS-5;
however, for TM 27.3, the values were found to be in the
0.5–4.0 % range. The limits of detection (LOD) were calcu-
lated as three standard deviations from the procedural blank
samples. LOQ values were calculated as three times of the
LOD values. LOD and LOQ values are gathered in Table 3.
Statistical Analysis
A detailed statistical analysis was performed with Statistica 10
for Windows. The normality of the variables’ distribution was
verified using the Shapiro–Wilk test. The Mann–Whitney U
test was used to compare differences between groups for all
the studied parameters. Simple associations between parame-
ters were calculated as the Spearman coefficient of correlation.
The level of statistical significance was set to p<0.05.
Results
The mean, range, and median concentrations of the essential
and toxic minerals in AF are shown in Table 4.
In this study, it was presumed that the factors most likely to
influence the mineral concentrations in amniotic fluid are as
follows: age of mothers, week of the pregnancy, and gender of
the fetus.
It has been postulated that pregnancy in women over
35 years of age is associated with an increased risk of
malformations. For this reason, subjects in this study were
divided into two groups according to age: those less than
35 years old (n=17) and those 35 years or older (n=22). It
was found that the concentration of magnesium was
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significantly lower and that the levels of nickel, cadmium,
barium, and chromium were markedly higher in the AF of
older women (Table 5).
The samples were also divided into two different groups
according to the gender of the fetus. A significant difference
was found in the vanadium concentration in AF, with higher
levels of vanadium shown in male fetuses than in female fe-
tuses (Table 6).
The amniotic fluid samples were divided into two addition-
al groups according to the week of pregnancy. The one of the
group was between 16 and 20 week of gestation and the sec-
ond group was between 21 and 26 week of gestation. The
markedly higher concentration of copper and lower level of
magnesium in the samples with longer period of pregnancy
was observed (Table 7).
Table 8 shows the correlation between mineral concentra-
tions in AF and selected maternal and fetal parameters. The
maternal and fetal parameters are summarized in Table 1.
Significant positive correlations between systolic blood pres-
sure and the level of uranium and manganese in AF, and be-
tween diastolic blood pressure and the levels of nickel, stron-
tium, cadmium, and manganese, were found. Moreover, a
markedly negative correlation between the current body mass
of women and the level of magnesium in AF was observed.
Furthermore, there was a significant correlation between fetal
parameters and magnesium and copper levels in AF.
Significant positive correlations were seen between magne-
sium and umbilical artery pulsatility index (UAPI), copper
and biparietal diameter (BPD), copper and abdominal circum-
ference (AC), copper and head circumference (HC), copper
and femur length (FL), and copper and estimated fetal weight
(EFW) (Table 7). Moreover, markedly negative correlations
between magnesium and BPD, HC, FL, and EFW were
observed.
Discussion
The concentration of minerals in amniotic fluid was affected
by maternal age, week of gestation, and gender of fetus. This
is a novel finding of our study. We also showed that the level
of minerals in AF correlates with some maternal and fetal
parameters. To the best of our knowledge, this is the first study
on pregnant women to demonstrate these relationships.
The range of concentration of some minerals in AF in this
study—especially copper, strontium, cobalt, manganese, and
barium—is in agreement with the results of other reports [1,
Table 2 Results of the measurements (n=10) of certified reference materials: SLRS-5 and TM 27.3 given with certified values
Analyte River water SLRS-5 Fortified lake water TM 27.3
Measured value (μg L−1) Certified value (μg L−1) Accuracy (%) Measured value (μg L−1) Certified value (μg L−1) Accuracy (%)
Al 46.84±0.65 49.5±5.0 95 42.8±1.7 44.4±5.1 96
As 0.448±0.039 0.413±0.039 109 2.258±0.030 2.15±0.30 105
Ba 14.6±1.3 14.0±0.5 104 15.96±0.21 14.9±1.1 107
Cd 0.0095±0.0021 0.0060±0.0014 159 1.110±0.014 1.05±0.12 106
Co 0.0607±0.0028 0.05a 121 1.888±0.020 2.05±0.18 92
Cr 0.289±0.044 0.208±0.023 139 1.953±0.010 1.73±0.33 113
Cu 17.07±0.54 17.4±1.3 98 6.01±0.12 6.16±0.61 98
Mg 2752±46 2540±160 108 – – –
Mn 4.12±0.32 4.33±0.18 95 2.232±0.016 2.27±0.35 98
Ni 0.589±0.016 0.476±0.064 124 2.396±0.070 2.44±0.53 98
Sr 52.40±0.65 53.6±1.3 98 98.4±1.4 105±6 94
U 0.0908±0.0090 0.093±0.006 98 2.094±0.075 2.03±0.19 103
V 0.360±0.049 0.317±0.033 114 2.170±0.042 2.18±0.25 100
a information value
Table 3 LOD and LOQ
values LOD (μg L
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4]. However, some other authors have observed lower levels
of aluminum, copper, nickel, strontium, and vanadium and
higher levels of barium and magnesium in amniotic fluid than
in this study [2, 4, 8]. There are several factors that may affect
the differences in the results obtained in various studies, such
as age of the mother, week of pregnancy, and the analytical
methods used. In this study, it was found that the concentra-
tion of metals such as nickel, cadmium, and barium increased
in AF with maternal age. It is possible that, in older mothers,
the period of exposure to metals was longer, and hence, the
accumulation of these minerals in the body of the mothers and
their passage into the AF was greater [9]. Higher concentra-
tions of metal in AF may suggest increased risks of abnormal
fetal development, because the fetus inhales and swallows
amniotic fluid at a turnover rate of one third of its volume
every hour [8]. In this study, it was observed that lower levels
of magnesium were found in the amniotic fluid of older
mothers. Low magnesium levels in AF are associated with
complications of pregnancy such as preeclampsia and diabetes
[3], and it is known that women with advanced maternal age
are at high risk of developing these diseases [10–12].
Moreover, the concentration of some minerals (including
magnesium) in women’s bodies may depend on age. It was
found that the concentration ofmagnesium in the hair of wom-
en of reproductive age was significantly lower in subjects in
the 31–40 age range than in younger or older subjects [13].
In the later weeks of gestation, the concentration of copper
in AF was significantly higher. This may be caused by longer
time of maternal exposure to this element from food, water,
and environment, and the increased secretion of copper in fetal
urine. It is known that the absorption of copper rises during
pregnancy due to the increasing need for maternal copper-
containing enzymes, and copper is also critical in fetal
development [1]. In this study, we observed the positive cor-
relations between copper concentration in AF and fetal bio-
metric parameters. Similar concentrations of copper in the AF
of women of similar age and in similar weeks of pregnancy
have been reported by other authors [14]. The increase in the
level of copper and other minerals in AF as pregnancy
progressed was also observed in experimental models in pigs
[15]. Because AF is swallowed by the fetus, Richards [15]
suggested that this fluid may be an important source of copper
for fetal nutrition. Increases in copper concentration in AF
may reflect an increasing level of this mineral in the mother’s
blood during pregnancy [16]. It was found that the concentra-
tion of trace elements in AF linearly correlates with maternal
serum [16]. Other authors have found that zinc in human AF
increases during pregnancy and that the most significant peri-
od for this rise is the third trimester [17].
In this study, the concentration of magnesium was lower in
the samples of amniotic fluid with longer gestational age in the
second trimester. These results were confirmed by the study of
Facchinetti et al. [18]. It is known that magnesium plays an
important role in pregnancy and fetal development. The fall in
levels of magnesium over the course of pregnancy can attest to
the fact that this essential mineral is used for building the body
and metabolism in the fetus. This finding is very important,
because magnesium deficiency may be a major factor of path-
ogenesis in complicated pregnancies and also may cause met-
abolic problems extending into adult life [19, 20].
In several studies, fetal gender was seen to relate to the
concentration of some AF components, such as cytokines,
hormones, and minerals [21–23]. Tzschoppe et al. [23] found
significantly higher concentrations of potassium, magnesium,
and phosphate in the AF of male fetuses. In this study, higher
levels of vanadium were seen in the amniotic fluid of male
Table 8 Correlation between mineral levels in amniotic fluid and maternal and fetal parameters
Parameters Mg Al Cu Co Ni As Sr Cd Ba V U Cr Mn
Maternal parameters
Sys −0.13 0.35 0.11 0.11 0.17 0.15 0.19 0.26 0.12 0.12 0.39* −0.01 0.45*
Dia −0.05 0.02 −0.06 0.10 0.36* −0.10 0.35* 0.46* 0.00 −0.11 0.15 0.14 0.37*
Body mass −0.45* −0.04 −0.02 −0.25 0.07 −0.29 −0.31 0.06 0.29 −0.31 −0.21 0.15 0.04
Fetal parameters
FHR 0.05 −0.15 0.09 −0.32 0.09 0.05 −0.15 −0.05 −0.12 0.27 −0.03 0.07 0.18
UAPI 0.40* 0.07 −0.27 −0.03 −0.09 0.02 0.14 0.00 −0.20 −0.10 0.12 −0.15 −0.09
BPD −0.39* 0.15 0.41* 0.15 0.16 −0.08 0.12 0.27 0.29 −0.08 0.09 0.25 0.20
HC −0.38* 0.13 0.41* 0.14 0.15 −0.11 0.12 0.25 0.30 −0.12 0.11 0.24 0.16
AC −0.27 0.09 0.40* 0.15 0.11 −0.08 0.11 0.21 0.19 −0.08 0.02 0.16 0.14
FL −0.40* 0.14 0.41* 0.14 0.22 −0.12 0.15 0.29 0.28 −0.13 0.03 0.27 0.25
EFW −0.34* 0.12 0.41* 0.13 0.17 −0.09 0.11 0.25 0.22 −0.09 0.00 0.24 0.20
Sys systolic blood pressure, Dia diastolic blood pressure, FHR fetal heart rate, UAPI umbilical artery pulsatility index, BPD biparietal diameter, AC
abdominal circumference, HC head circumference, FL femur length, EFW estimated fetal weight
*Spearman correlation (R), p<0.05
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fetuses than of female fetuses. These results may point to sex-
specific differences in physiological or hormonal changes in
fetuses. Confirmation of such differences is provided by one
study that showed that male fetal gender is associated with
higher levels of proinflammatory cytokines and angiogenic
factors in the mother’ s blood than female fetal gender [24].
It is known that vanadium is a factor associated with the pro-
cess of angiogenesis [25], and this may also partly explain the
present study’s results.
It was found that high blood pressure in mothers
correlated with higher concentration of nickel, stron-
tium, cadmium, uranium, and manganese in AF.
Relationships between the levels of these metals and
high blood pressure in different populations (including
in pregnant women) have been demonstrated in several
studies [26–30]. Since amniotic fluid is swallowed by
the fetus, higher levels of metals in this fluid may lead
to an increased risk of hypertension in the child.
The significant correlations that were observed be-
tween minerals in the AF and the fetal parameters are
partially confirmed by the results for gestational age
(Tables 7 and 8). As pregnancy proceeded, the concen-
tration of copper in AF increased and magnesium con-
centration decreased. Moreover, fetal growth parameters
such as BPD, AC, HC, FL, and EFW are negatively
correlated with the concentration of magnesium and
positively correlated with the level of copper in the AF.
In this study, a significant positive correlation was found
between the magnesium level in AF and umbilical artery
pulsatility index (UAPI). The association between these pa-
rameters was also demonstrated in other studies [31–33].
Moreover, it was observed that the UAPI value, like the mag-
nesium concentration, decreases with gestational age [18, 31].
This study has some limitations. In particular, the
size of the group was small, and so this research is
rather a pilot study. Due to the small group size, we
could not attempt to establish reference values for the
concentrations of minerals in the amniotic fluid at given
gestational ages. We analyzed only certain minerals in
the amniotic fluid, but not in the mother’s blood or in
the umbilical cord blood, which would allow broader
conclusions about the association between mineral status
and fetal development. Moreover, the daily intake and
eating habits of the mothers’ were not included in this
study, and therefore, it was not possible to determine
the influence of mothers’ diet on minerals concentration
in the amniotic fluid samples.
In conclusion, our results suggest a relationship be-
tween mineral level in AF and fetal development. These
findings can present an additional opportunity for diag-
nosing fetal development. Further investigations with a
larger group of pregnant women is needed to explain
the mechanism of this association and to determine of
the reference values for mineral levels in the amniotic
fluid at various stages of pregnancy.
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